EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeitOpen Access · CC BY 4.0

Palbociclib in Patients With HR+/HER2− Advanced or Metastatic Breast Cancer and Bone-Only Metastasis: A Systematic Literature Review

Joyce O'Shaughnessy, Nusrat Jahan, Anna Louise Barry, Rebecca Jean Watters, Beata Korytowsky, Diana Avery, Vinay Pasupuleti, Andrew Proctor

Clinical Breast Cancer · 2026-06 · 26 (6) · 113-127

DOI: 10.1016/j.clbc.2026.04.010 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Breast Cancer, 2026-06. Verfasst von Joyce O'Shaughnessy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Texas Oncology and US Oncology, Baylor University Medical Center, Dallas, TX. Hauptthemen laut MEDLINE: Piperazines, Breast Neoplasms, Pyridines, Bone Neoplasms. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperazinesBreast NeoplasmsPyridinesBone NeoplasmsProtein Kinase InhibitorsAntineoplastic AgentsHumansFemaleErb-b2 Receptor Tyrosine KinasesQuality of LifeReceptors, ProgesteroneReceptors, EstrogenRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Advanced breast cancerBone-only metastasisCDK4/6 inhibitorHR+/HER2−Metastatic breast cancerPalbociclib

Substanzen

PiperazinespalbociclibPyridinesErb-b2 Receptor Tyrosine KinasesProtein Kinase InhibitorsERBB2 protein, humanReceptors, ProgesteroneReceptors, EstrogenAntineoplastic Agents

Autor:innen und Institutionen

  • Texas Oncology and US Oncology, Baylor University Medical Center, Dallas, TX.
  • Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
  • Pfizer Ltd, Surrey, UK.
  • Pfizer Inc, New York, NY.
  • Oxford PharmaGenesis Inc, Wilmington, DE.
  • Department of Oncology, York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK. Electronic address: andrewproctor@nhs.net.

Förderung

  • Pfizer Inc

Zitieren

APA

O'Shaughnessy, J., Jahan, N., Barry, A. L., Watters, R. J., Korytowsky, B., Avery, D., Pasupuleti, V., & Proctor, A. (2026). Palbociclib in Patients With HR+/HER2− Advanced or Metastatic Breast Cancer and Bone-Only Metastasis: A Systematic Literature Review. Clinical Breast Cancer, 26(6), 113-127. https://doi.org/10.1016/j.clbc.2026.04.010

Vancouver

O'Shaughnessy J, Jahan N, Barry AL, Watters RJ, Korytowsky B, Avery D, et al. Palbociclib in Patients With HR+/HER2− Advanced or Metastatic Breast Cancer and Bone-Only Metastasis: A Systematic Literature Review. Clinical Breast Cancer. 2026;26(6):113-127. doi:10.1016/j.clbc.2026.04.010

BibTeX
@article{OShaughnessy2026,
  author = {O'Shaughnessy, Joyce and Jahan, Nusrat and Barry, Anna Louise and Watters, Rebecca Jean and Korytowsky, Beata and Avery, Diana and Pasupuleti, Vinay and Proctor, Andrew},
  title = {Palbociclib in Patients With HR+/HER2− Advanced or Metastatic Breast Cancer and Bone-Only Metastasis: A Systematic Literature Review},
  journal = {Clinical Breast Cancer},
  year = {2026},
  volume = {26},
  number = {6},
  pages = {113--127},
  doi = {10.1016/j.clbc.2026.04.010}
}
Kostenlos starten →